Clinical Integration Program definition

Clinical Integration Program means the active and ongoing program of clinical quality, efficiency, and cost effectiveness initiatives developed, implemented, and operated by GSQN on behalf of and in collaboration with GSQN Members and GSQN participating physician practices.
Sample 1Sample 2Sample 3
Clinical Integration Program means a formal, non-exclusive, active and ongoing program of clinical quality initiatives developed, implemented, and operated by CIN in collaboration with Provider in order to create a high degree of coordination and interdependence among Participating Providers with the intent to increase value and efficiency, and improve patient outcomes and includes one or more of the following operating protocols:
Sample 1
Clinical Integration Program or “CI Program” shall mean the program of Clinical Integration developed, implemented, and operated by CIN on behalf of and in collaboration with CIN’s Participants and Participating Practices.
Sample 1

Examples of Clinical Integration Program in a sentence

  • Expense reports are then reviewed by each employee’s manager and audited by the Debtors using a risk- and artificial intelligence-based audit system.

  • Care Delivery ReformTo transform care delivery, the SIM launched the Community and Clinical Integration Program (CCIP), which enables Advanced Networks and FQHCs to improve care delivery through targeted technical assistance, transformation awards, and participation in community health collaboratives.

  • ORDER acknowledging receipt of Minutes and Expenditures of the Harrison County Development Commission for the meetings of May 31, 2005; June 15, 2005; June 22, 2005; June 23, 2005; June 27, 2005; and June 28, 2005, received by and on file with the Clerk of the Board/ County Auditor, per Sec.

  • The Community and Clinical Integration Program (CCIP) states as a goal “introducing new care processes to reduce health equity gaps” (p.

  • The Task Force has previously recognized the value of pharmacists and Comprehensive Medication Management (CMM) by including elective CMM standards in the Community and Clinical Integration Program (CCIP).

  • The PTN program administrators will work in collaboration with the SIM PMO to review the SIM Community and Clinical Integration Program (CCIP) standards and consider whether and to what extent these standards could be incorporated into the PTN change package in a manner that will advance the programs’ mutual 19 Discussions have also been held with VHA/UHC, however, the VHA/UHC clinician recruitment plan does not currently include Connecticut-based clinicians.

  • Additionally, this demonstration could help the SIM Community and Clinical Integration Program (CCIP) advanced networks and FQHCs to add pharmacists on care teams to implement core and elective practice standards, (i.e., complex care management, comprehensive medication management, and e-consults).

  • In terms of reviewers, there is a pressing need for the participant Ukrainian universities to go ahead and develop reviewer communities as this will be key for the success of the platform and the OPTIMA project at large.

  • Noncompliance with Clinical Integration Program initiatives or goals.

  • Appendix C: Community & Clinical Integration Program – Community Health Collaboratives COMMUNITY HEALTH COLLABORATIVES Program Context, Description, and Objective:Context: One of the core drivers of better healthcare outcomes in Connecticut’s SIM Community and Clinical Integration Program initiative is the integration of healthcare delivery with community resources.

Related to Clinical Integration Program

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Development Program means the implementation of the development plan.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, or Pivotal Study, as applicable; but excluding any Post-Approval Studies.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Diagnostic source assembly means the tube housing assembly with a beam-limiting device attached.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Diagnostic x-ray system means an x-ray system designed for irradiation of any part of the human or animal body for the purpose of diagnosis or visualization.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Research Program has the meaning set forth in Section 2.1.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Nuclear fuel cycle-related research and development activities means those activities which are specifically related to any process or system development aspect of any of the following: - conversion of nuclear material, - enrichment of nuclear material, - nuclear fuel fabrication, - reactors, - critical facilities, - reprocessing of nuclear fuel, - processing (not including repackaging or conditioning not involving the separation of elements, for storage or disposal) of intermediate or high-level waste containing plutonium, high enriched uranium or uranium-233, but do not include activities related to theoretical or basic scientific research or to research and development on industrial radioisotope applications, medical, hydrological and agricultural applications, health and environmental effects and improved maintenance.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Software Product means any COTS which you propose to provide pursuant to the contract.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.